Alexion Pharmaceuticals Inc. develops pharmaceutical products for the treatment of heart disease, inflammation, diseases of the immune system and cancer in humans. The Company's two lead product candidates are genetically altered antibodies that target specific diseases that arise when the human immune system induces undesired 1inflammation in the human body